2024-04-01 13270333 2025-03-31 13270333 2024-04-01 2025-03-31 13270333 2024-03-31 13270333 2023-04-01 2024-03-31 13270333 uk-core:ShareCapital 2025-03-31 13270333 uk-core:ShareCapital 2024-03-31 13270333 uk-bus:Director1 2024-04-01 2025-03-31 iso4217:GBP 13270333 uk-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 13270333 uk-bus:FRS102 2024-04-01 2025-03-31 13270333 uk-bus:FilletedAccounts 2024-04-01 2025-03-31 13270333 uk-bus:EntityNoLongerTradingButTradedInPast 2024-04-01 2025-03-31 13270333 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31

Tsamedicals Ltd

Registered Number:13270333

For the year ended 31 March 2025
England and Wales
Unaudited Financial Statements

2
For the year ended 31 March 2025
Tsamedicals Ltd
Contents Page
1
Statement of Financial Position
2
Notes to the Financial Statements
3

Registered Number :

13270333

As at 31 March 2025

Tsamedicals Ltd
Statement of Financial Position

£

£

2024
2025

Current assets

1

Cash and cash equivalents

-
-
1

Total assets less current liabilities

-
1
-
Net assets/liabilities
1

Capital and reserves

Called up share capital

-
1
-
1
Shareholders' funds

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006

The director acknowledges her responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Ms Susan Taiwo Adebanyo Director

These financial statements were approved and authorised for issue by the Board on 09 December 2025 and were signed by:

The notes form part of these financial statements

1 of 2
4
For the year ended 31 March 2025
Tsamedicals Ltd
Notes to the Financial Statements
Statutory Information

Tsamedicals Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number
13270333.

Registered address:

11 Forest Hill
Maidstone
England
ME15 6UX

The presentation currency is £ sterling.

1. Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1 A of Financial
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.

2 of 2